NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Radioprotective Thiolamines WR-1065 and WR-33278 Selectively Denature Nonhistone Nuclear ProteinsDifferential scanning calorimetry was used to study the interactions of nuclei isolated from Chinese hamster V79 cells with the radioprotector WR-1065, other thiol compounds, and polyamines. Differential scanning calorimetry monitors denaturation of macromolecules and resolves the major nuclear components (e.g. constrained and relaxed DNA, nucleosome core, and nuclear matrix) of intact nuclei on the basis of thermal stability. WR-1065 treatment (0.5-10 mM) of isolated nuclei led to the irreversible denaturation of nuclear proteins, a fraction of which are nuclear matrix proteins. Denaturation of 50% of the total nonhistone nuclear protein content of isolated nuclei occurred after exposure to 4.7 mM WR-1065 for 20 min at 23 C. In addition, a 22% increase in the insoluble protein content of nuclei isolated from V79 cells that had been treated with 4 mM WR-1065 for 30 min at 37 C was observed, indicating that WR-1065-induced protein denaturation occurs not only in isolated nuclei but also in the nuclei of intact cells. From the extent of the increase in insoluble protein in the nucleus, protein denaturation by WR-1065 is expected to contribute to drug toxicity at concentrations greater than approximately 4 mM. WR-33278, the disulfide form of WR1065, was approximately twice as effective as the free thiol at denaturing nuclear proteins. The proposed mechanism for nucleoprotein denaturation is through direct interactions with protein cysteine groups with the formation of destabilizing protein-WR-1065 disulfides. In comparison to its effect on nuclear proteins in isolated nuclei, WR-1065 had only a very small effect on non-nuclear proteins of whole cells, isolated nuclear matrix, or the thiol-rich Ca (2+) ATPase of sarcoplasmic reticulum, indicating that WR-1065 can effectively denature protein only inside an intact nucleus, probably due to the increased concentration of the positively charged drug in the vicinity of DNA.
Document ID
20000112937
Acquisition Source
Goddard Space Flight Center
Document Type
Reprint (Version printed in journal)
Authors
Booth, Valerie K.
(Waterloo Univ. Ontario Canada)
Roberts, Jeanette C.
(Utah Univ. Salt Lake City, UT United States)
Warters, Raymond L.
(University of Utah Health Sciences Center Salt Lake City, UT United States)
Wilmore, Britta H.
(Utah Univ. Salt Lake City, UT United States)
Lepock, James R.
(Waterloo Univ. Ontario Canada)
Date Acquired
August 19, 2013
Publication Date
January 1, 2000
Publication Information
Publication: Radiation Research
Publisher: Radiation Research Society
Volume: 153
ISSN: 0033-7587
Subject Category
Life Sciences (General)
Funding Number(s)
CONTRACT_GRANT: NIH-5P30CA42014
CONTRACT_GRANT: NIH-5R29GM22785
CONTRACT_GRANT: NAG5-4452
Distribution Limits
Public
Copyright
Other

Available Downloads

There are no available downloads for this record.
No Preview Available